Publications of S. Lucae
All genres
Journal Article (198)
121.
Journal Article
67 (4), pp. 348 - 359 (2010)
Association of Genetic Variants in the Neurotrophic Receptor-Encoding Gene NTRK2 and a Lifetime History of Suicide Attempts in Depressed Patients. Archives of General Psychiatry 122.
Journal Article
20 (Suppl. 1), pp. S15 - S16 (2010)
Association of the adrenergic receptor alpha1B with antidepressant treatment in the MARS study. European Neuropsychopharmacology 123.
Journal Article
20 (Suppl. 1), pp. S85 - S86 (2010)
Somatisation in major depression, genetic association and clinical features. European Neuropsychopharmacology 124.
Journal Article
35 (3), pp. 727 - 740 (2010)
Polymorphisms in GRIK4, HTR2A, and FKBP5 Show Interactive Effects in Predicting Remission to Antidepressant Treatment. Neuropsychopharmacology 125.
Journal Article
20 (1), pp. 65 - 68 (2010)
HTR2A gene variation is involved in antidepressant treatment response. European Neuropsychopharmacology 126.
Journal Article
73, pp. 665 - 666 (2009)
Pharmacogenetics of antidepressant treatment outcome - Results from a genome-wide multilocus analysis including clinical predictors. Annals of Human Genetics 127.
Journal Article
42 (5), p. 222 - 222 (2009)
Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - Findings from the Munich Antidepressant Response Signature project. Pharmacopsychiatry 128.
Journal Article
42 (5), p. 223 - 223 (2009)
Association of the adrenergic receptor alpha1B with antidepressant treatment in the MARS study. Pharmacopsychiatry 129.
Journal Article
66 (9), pp. 966 - 975 (2009)
A Genomewide Association Study Points to Multiple Loci That Predict Antidepressant Drug Treatment Outcome in Depression. Archives of General Psychiatry 130.
Journal Article
42 (5), p. 224 - 224 (2009)
A genome-wide association study points to multiple loci predicting antidepressant treatment outcome in depression. Pharmacopsychiatry 131.
Journal Article
42 (5), p. 226 - 226 (2009)
Polymorphisms in tryptophan hydroxylase 2 leading to decreased serotonergic activity contribute to elevated risk for metabolic syndrome in depression. Pharmacopsychiatry 132.
Journal Article
42 (5), p. 230 - 230 (2009)
The neuronal transporter gene SLC6A15 confers risk to major depression. Pharmacopsychiatry 133.
Journal Article
42 (5), p. 233 - 233 (2009)
Biomarkers for the combined efficacy of cognitive behavioral therapy in antidepressant treatment in depression. Pharmacopsychiatry 134.
Journal Article
8 (4), pp. 464 - 472 (2009)
Investigation of 17 candidate genes for personality traits confirms effects of the HTR2A gene on novelty seeking. Genes Brain and Behavior 135.
Journal Article
116 (6), pp. 649 - 657 (2009)
The GABA transporter 1 (SLC6A1): a novel candidate gene for anxiety disorders. Journal of Neural Transmission 136.
Journal Article
65 (8 Suppl. S), p. 230S - 230S (2009)
Association of the Adrenergic Receptor Alpha l B with Antidepressant Treatment in the MARS Study. Biological Psychiatry 137.
Journal Article
65 (8 Suppl. S), p. 231S - 231S (2009)
Gene-Environment Interaction of the Leptin Receptor (LEPR) Gene and Severe Trauma Moderates Depressive Symptoms and HPA-Axis Function. Biological Psychiatry 138.
Journal Article
39 (4), pp. 603 - 614 (2009)
Cognitive impairment in unipolar depression is persistent and non-specific: further evidence for the final common pathway disorder hypothesis. Psychological Medicine 139.
Journal Article
14 (4), pp. 359 - 375 (2009)
Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Molecular Psychiatry 140.
Journal Article
19 (Suppl. 1), pp. S68 - S69 (2009)
Clinical characteristics and treatment outcome in a representative sample of depressed inpatients. European Neuropsychopharmacology